- Home
- ESPR vs RLGT Comparison
ESPR vs RLGT Comparison
Compare ESPR & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESPR | RLGT |
|---|---|---|
| Founded | 2008 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 291.6M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESPR | RLGT |
|---|---|---|
| Price | $3.73 | $6.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $6.67 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 4.9M | 160.6K |
| Earning Date | 11-06-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.35 |
| EPS | N/A | ★ 0.31 |
| Revenue | $303,802,000.00 | ★ $925,786,000.00 |
| Revenue This Year | $26.11 | $3.77 |
| Revenue Next Year | N/A | $3.51 |
| P/E Ratio | ★ N/A | $20.91 |
| Revenue Growth | 2.83 | ★ 16.42 |
| 52 Week Low | $0.69 | $5.44 |
| 52 Week High | $4.13 | $7.94 |
Technical Indicators
Market Signals| Indicator | ESPR | RLGT |
|---|---|---|
| Relative Strength Index (RSI) | 51.07 | 62.13 |
| Support Level | $3.63 | $6.28 |
| Resistance Level | $3.89 | $6.55 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 20.00 | 79.46 |
Price Performance
Historical ComparisonAbout ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.